Hudson Bay Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-135,000
Closed -$1.27M 1031
2024
Q3
$1.27M Sell
135,000
-115,000
-46% -$1.09M 0.01% 625
2024
Q2
$2M Buy
250,000
+200,000
+400% +$2.14M 0.02% 525
2024
Q1
$741K Sell
50,000
-225,000
-82% -$2.62M 0.01% 564
2023
Q4
$2.24M Sell
275,000
-155,200
-36% -$812K 0.02% 430
2023
Q3
$1.96M Buy
430,200
+155,200
+56% +$1.01M 0.02% 485
2023
Q2
$1.94M Sell
275,000
-218,553
-44% -$1.56M 0.02% 509
2023
Q1
$3.02M Buy
493,553
+185,553
+60% +$1.28M 0.03% 436
2022
Q4
$1.97M Buy
308,000
+208,000
+208% +$1.62M 0.02% 610
2022
Q3
$958K Hold
100,000
0.01% 855
2022
Q2
$1.1M Buy
100,000
+75,000
+300% +$983K 0.01% 907
2022
Q1
$416K Buy
+25,000
New +$387K 0.01% 885

Other funds holding IOVA